Logo

Klinik Kesihatan Buloh Kasap

COPD CALCULATOR

Assess GOLD Severity, Symptoms (CAT/mMRC), and Exacerbation Risk.

Patient Parameters

%
Determines airflow limitation severity (GOLD 1 - 4).
Determines exacerbation risk category.

Choose one or both tools to assess symptom burden. The system will use the highest severity.

mMRC Scale
--
CAT Score
--

GOLD Classification

AIRFLOW LIMITATION

GOLD -

Pending FEV1

ASSESSMENT GROUP

GROUP -

Pending Symptoms/Risk
Awaiting Data...

Please enter FEV1, exacerbation history, and at least one symptom score to view recommendations.

*Based on the latest GOLD 2023/2024 Guidelines (A, B, E Classification)

COPD Pharmacotherapy Reference Guide

Short-Acting (Relievers)

SABA (Beta2-Agonists):

  • Salbutamol (Ventolin)
  • Terbutaline (Bricanyl)

SAMA (Muscarinic Antagonists):

  • Ipratropium bromide (Atrovent)
Long-Acting (Maintenance)

LABA:

  • Salmeterol (Serevent)
  • Formoterol (Oxis)
  • Indacaterol (Onbrez)

LAMA:

  • Tiotropium (Spiriva)
  • Umeclidinium (Incruse)
  • Glycopyrronium (Seebri)
Combination Therapies

LABA + LAMA (Dual):

  • Indacaterol/Glycopyrronium (Ultibro)
  • Vilanterol/Umeclidinium (Anoro)
  • Tiotropium/Olodaterol (Spiolto)

LABA + LAMA + ICS (Triple):

  • Fluticasone/Umeclidinium/Vilanterol (Trelegy)
  • Beclometasone/Formoterol/Glycopyrronium (Trimbow)